| EX0189 BCR-ABL QUANTITATIVE, MRD MONITOR |
| Specimen: |
5 mL (3 mL min.) whole blood / Bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. |
| Stability: |
| Room |
Refrigerated |
Frozen |
| NA |
4 days |
NA |
|
| Method: |
Real-Time PCR |
| Comment: |
|
| Report: |
Sample Mon through Sat by 10 am; Report Next working day |
| Usage: |
BCR-ABL is a fusion gene formed by the rearrangement of the breakpoint cluster region (BCR) on chromosome 22 with the ABL proto-oncogene on chromosome 9 leading to the formation of the Philadelphia chromosome. This rearrangement is seen in almost 95% of patients with CML. The Quantitative assay helps in the management of the disease and monitors the effect of therapy. |
| Doctor Specialty: |
Hematologist, Oncologist |
| Disease: |
Leukemia |
| Components: |
|
| Courier Charges: |
|
| Home Collection: |
Available (*T&C Apply) |
| Department: |
MOLECULAR DIAGNOSTICS |
| Pre Test Information: |
A duly filled MRD Requisition Form with historical data is mandatory. |
Reviews
There are no reviews yet.